ArticleCancers2024

Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer.

Takafumi Morisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.